Resources
Access a comprehensive library of tools, reports, demos, and expert insights with our Resources Hub, designed to enhance your business strategies and outcomes.
Blog
Articles and data-driven insights about real-world evidence and technology innovations
Webinars & Events
Explore our upcoming live sessions and in-person events, and access our extensive on-demand webinar library to stay informed and ahead in the industry.
Let’s Talk Use Cases: Where AI Accelerates Early Commercialization and Where It Falls Short
See how AI and human expertise work together to advance early commercialization, driving smarter strategies, stronger insights, and better outcomes across the industry.
Breakthrough AI for Healthcare Analytics: The Official Komodo Launch Event
Meet Marmot™, Komodo’s revolutionary AI engine designed to be your thought partner, helping you make faster, smarter decisions with confidence.
Show Me Your Architecture: How Komodo Health Enables Analytics with an Open Lakehouse
Explore how to leverage Snowflake’s platform — eliminating data silos and simplifying architecture — to enhance interoperability and power your suite of applications.
Publications
Explore published research, Qualified Entity (QE) reports, and white papers made possible by our research-grade real-world data. For information on a specific study or topic, or to learn more, email us at [email protected].
Press
Stay informed with Komodo’s newsroom: your source for company updates, product launches, and industry insights. Journalists can reach the Komodo Health Media team at: [email protected].
Multi-year collaboration leverages real-world data and healthcare-native AI to modernize the development of quality measures
NEW YORK, SAN FRANCISCO — August 26, 2026 — Komodo Health®, an AI-powered healthcare intelligence company, today announced a multi-year strategic effort with the National Committee for Quality Assurance (NCQA) to modernize how healthcare quality measures are developed, validated, and continuously improved.
For more than 35 years, NCQA has advanced healthcare quality through transparency and accountability, with its Healthcare Effectiveness Data and Information Set (HEDIS®), serving as one of healthcare’s most widely used performance improvement tools across commercial, Medicaid, and Medicare health plans, as well as other healthcare organizations. As care delivery evolves, NCQA is advancing HEDIS toward a more focused, meaningful portfolio of measures that delivers clearer, more actionable signals to improve care, accountability, and value. Achieving that vision requires both the right measures and the ability to develop, validate, and refresh them quickly enough to keep pace with clinical evidence and real-world care.
Traditionally, developing new quality measures required assembling fragmented datasets from multiple sources, resulting in lengthy development and testing cycles. Through this collaboration, NCQA is leveraging Komodo’s Healthcare Map®, the industry’s most comprehensive view of more than 330 million de-identified patient journeys, to analyze care across insurance types, care settings, and patient populations from a single longitudinal data source.
Marmot™, Komodo’s healthcare-native analytics AI platform, powered by the Healthcare Map, will also enable NCQA researchers to rapidly explore complex healthcare questions while producing transparent, reproducible analyses grounded in real-world evidence. Together, these capabilities allow NCQA to evaluate new measures more quickly and efficiently, and ensure HEDIS continues to reflect the realities of modern healthcare without compromising the scientific rigor and transparency that quality measurement demands.
“The future of quality measurement depends on our ability to ensure measures remain meaningful, actionable, and aligned with how care is delivered,” said Tricia Elliott, Vice President, Quality Implementation, NCQA. “By working with Komodo, we’re advancing a more dynamic approach to quality measurement, one that enables us to develop and evolve HEDIS measures across commercial, Medicaid, and Medicare populations with greater speed while remaining grounded in rigorous evidence.”
The collaboration has already supported the development and testing of a new HEDIS measure: Follow-Up After Positive Colorectal Cancer Non-Invasive Screening Test (COF-E). The measure evaluates whether patients receive a timely colonoscopy following a positive non-invasive colorectal cancer screening result, supporting earlier detection and treatment, and will be implemented in Measurement Year 2027.
Historically, quantitatively testing a new HEDIS measure has taken two to three months. With Komodo’s capabilities, NCQA tested the COF-E measure in about a month for Medicare Advantage, Medicaid, and commercial populations, demonstrating how comprehensive real-world data can accelerate rigorous, evidence-based measure development.
“This effort underscores the power of real-world evidence and trusted, healthcare-native AI that enables healthcare organizations to better understand what’s happening across patient populations,” said Miles Ennis, President of Komodo Health. “We’re proud to support NCQA as they work to ensure quality measurement evolves alongside advances in healthcare delivery and continues to drive better outcomes for patients.”
NCQA will continue leveraging Komodo’s capabilities to support the development and evolution of additional HEDIS measures.
About Komodo Health
Komodo Health® is building the trusted AI-powered intelligence layer for healthcare and Life Sciences. Powered by the Healthcare Map®, the industry’s most comprehensive view of more than 330 million de-identified patient journeys, Komodo’s healthcare-native AI analytics platform, Marmot™, equips organizations with the intelligence needed to answer critical healthcare questions across clinical development, market access, commercialization, and real-world evidence. Designed for transparency, auditability, and reproducibility, Marmot enables teams to move from question to decision with greater speed and confidence. For more information, visit komodohealth.com.
About NCQA
NCQA is an independent nonprofit organization that defines and drives healthcare quality through accreditation, standards, performance measurement, and expert support. For more than 35 years, NCQA has advanced transparency, accountability, and enabled healthcare organizations to deliver better outcomes for patients. NCQA’s Healthcare Effectiveness Data and Information Set (HEDIS®) is one of healthcare’s most widely used performance improvement tools. Learn more at ncqa.org. Follow NCQA on X @ncqa and on LinkedIn linkedin.com/company/ncqa.
Media Contact
Tate LaCasse
Senior PR Manager
[email protected]
Expanded agreement extends Marmot across key enterprise functions, advancing a new operating model for AI-powered decision-making in Life Sciences
Komodo also unveils new Marmot capabilities to move organizations beyond AI experimentation and into enterprise-wide intelligence
NEW YORK, SAN FRANCISCO — June 25, 2026 — Komodo Health®, the leader in AI-powered healthcare intelligence, today announced an expanded strategic partnership with Alnylam Pharmaceuticals (Nasdaq: ALNY), the leading RNAi therapeutics company to scale Marmot™, Komodo’s analytics AI platform, across key enterprise functions at Alnylam.
Built on the Healthcare Map®, the industry’s most comprehensive view of more than 330 million de-identified patient journeys, Marmot helps organizations move beyond fragmented analytics and static reporting toward real-time, transparent, and reproducible healthcare intelligence. Launched in August 2025, Alnylam was an early adopter of the platform, with the collaboration initially focused on building custom AI agents for Alnylam’s commercial business function.
The expanded partnership will enable Alnylam to deploy Marmot across its customer-facing organization and leverage its capabilities more broadly across the enterprise, creating a unified foundation for data-driven decision-making at scale.
“Alnylam’s ability to create meaningful impact is built on breakthrough science, strong execution, and an unwavering commitment to patients,” said Tolga Tanguler, Chief Commercial Officer at Alnylam. “This new capability strengthens our ability to connect insight into action, helping us scale more effectively, accelerate decision-making, and continue delivering sustainable growth while maintaining our focus on patients.”
Since initially deploying Marmot, Alnylam and Komodo have built and deployed custom AI agents across critical workflows. Alnylam has integrated a wide range of enterprise datasets into the platform, transforming how teams access and act on insights by eliminating reliance on fragmented dashboards, reducing reporting cycles from months to hours, and enabling teams to generate insights that were previously out of reach. Marmot will continue to support Alnylam as the company works toward a range of operational and patient impact objectives.
Advancing the Next Generation of Enterprise Healthcare AI
The expanded partnership reflects a broader shift occurring across healthcare and Life Sciences as organizations move beyond AI experimentation and begin adopting new operating models built around real-time intelligence. As the limitations of disconnected dashboards, static reporting, and siloed analytics become increasingly apparent, the focus is turning toward enterprise-wide systems that can continuously generate, distribute, and operationalize trusted, verifiable insights across teams.
“We’re moving from a world where every team operates from its own reports and analyses to one where an entire enterprise sees the same reality in real time and can act on it,” said Arif Nathoo, MD, CEO and Co-Founder of Komodo Health. “Marmot is not only a productivity improvement; it’s a new operating model. Alnylam is demonstrating what becomes possible when AI evolves into an intelligence layer that powers how an organization runs.”
New Marmot Capabilities Support Enterprise-Wide Adoption
To support this next phase of enterprise AI adoption, Komodo also released several new Marmot capabilities designed to make healthcare intelligence accessible to every user, from business leaders and consultants to analysts and data scientists. These latest capabilities deliver unprecedented visibility, knowledge, and control over healthcare data, ensuring every analysis is reproducible, verifiable, and executed with unmatched speed and confidence.
“The organizations seeing the greatest value from AI aren’t simply generating insights faster; they’re embedding trusted intelligence directly into the workflows that drive critical decisions,” said Amit Sangani, Chief Technology Officer at Komodo. “These new capabilities are designed to help organizations move beyond experimentation and build AI into the core processes that drive the enterprise, without sacrificing the scientific rigor healthcare demands.”
To learn more, register for today’s live launch event at 1 PM ET/ 10 AM PT or visit our Product Updates page.
About Komodo Health
Komodo Health® is building the trusted AI-powered intelligence layer for healthcare and Life Sciences. Powered by the Healthcare Map®, the industry’s most comprehensive view of more than 330 million de-identified patient journeys, Komodo’s healthcare-native AI analytics platform, Marmot™, equips organizations with the intelligence needed to answer critical healthcare questions across clinical development, market access, commercialization, and real-world evidence. Designed for transparency, auditability, and reproducibility, Marmot enables teams to move from question to decision with greater speed and confidence.
Media Contact
Tate LaCasse
PR Manager
[email protected]
Leadership evolution strengthens Komodo’s position as the leading vertical AI company in healthcare and Life Sciences
NEW YORK & SAN FRANCISCO — June 16, 2026 — Komodo Health®, the leader in AI-powered healthcare intelligence, today announced an evolution of its executive leadership structure to accelerate the company’s next phase of growth and reinforce its position as the leading vertical AI company in healthcare and Life Sciences.
As part of this evolution, Miles Ennis has been appointed President, and co-Founder Web Sun will assume the role of co-Chief Executive Officer alongside co-Founder and CEO Arif Nathoo, MD.
This leadership evolution comes as healthcare and Life Sciences organizations move beyond AI experimentation and into enterprise-scale adoption. As teams increasingly seek trusted, healthcare-native AI solutions, Komodo’s healthcare-native AI platform Marmot™ enables organizations to build an enterprise-wide, real-time intelligence layer that generates verifiable, reproducible evidence and answers complex business questions in minutes.
“The next era of healthcare AI will be defined by vertical AI platforms that combine deep domain expertise, trusted data foundations, and purpose-built intelligence, and we believe Komodo is positioned to lead that category,” said Nathoo. “We have tremendous confidence in the opportunity ahead and are committed to continuing to invest in our platform, our people, and our partners to meet the growing demand for healthcare-native AI.”
Ennis joined Komodo Health as Chief Revenue Officer in July 2024 and was appointed Chief Operating Officer in September 2025. Since joining Komodo, he has helped lead one of the strongest growth periods in the company’s history, accelerating the commercialization and adoption of Marmot, and deepening strategic relationships across its partner ecosystem.
“Healthcare and Life Sciences organizations are moving beyond AI pilots and looking for solutions that work at enterprise scale, built on data they can trust and a platform designed for the complexity of healthcare,” said Ennis. “That is exactly what Komodo delivers, and as President, my focus will be to ensure our platform delivers measurable value and impact for the organizations we serve.”
As President, Ennis will focus on scaling Komodo’s commercial and operational capabilities, overseeing global go-to-market, operations, product strategy alignment, and marketing functions to align product innovation with customer needs, and strengthening execution across the business as demand for healthcare-native AI continues to grow.
“This evolved leadership structure reflects the scale of the opportunity ahead and the operating complexity of this next phase of growth,” said Sun. “Miles has consistently demonstrated the ability to connect strategy, product innovation, customer needs, and execution, a capability that becomes even more important as AI reshapes what is possible in healthcare and Life Sciences.”
About Komodo Health
Komodo Health is building the trusted AI-powered intelligence layer for healthcare and Life Sciences. Powered by the Healthcare Map®, the industry’s most comprehensive view of more than 330 million de-identified patient journeys, Komodo’s healthcare-native AI analytics platform, Marmot, equips organizations with the intelligence needed to answer critical healthcare questions across clinical development, market access, commercialization, and real-world evidence. Designed for transparency, auditability, and reproducibility, Marmot enables teams to move from question to decision with greater speed and confidence. For more information, visit komodohealth.com.
Media Contact
Tate LaCasse
PR Manager
[email protected]